Efficacy of a Web-based Weight Loss Program
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jul 5, 2012
Trial Information
Current as of May 30, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 30-65 years
- • body Mass Index: 27-39,9 kg/m2
- • ECOG-Performance status degree 0 or 1
- • basal internet skills
- • private internet access
- • signed informed consent
- Exclusion Criteria:
- • malign diseases
- • major organ diseases
- • inflammatory bowel diseases
- • insulin - dependent diabetes mellitus
- • pregnancy, breast feeding
- • treatment of eating disorders (e.g. bulimia, anorexia nervosa) within past 5 years
- • parallel participation in other weight loss programs or other trials
- • weight loss \> 5% within past 6 month
- • chronic therapy with glucocorticoids
- • subjects treated because of psychiatric disorders (e.g. schizophrenia, bipolar disorder) in the past
- • subjects with expected non-compliance to protocol guidelines
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Regensburg, , Germany
Vienna, , Austria
Berlin, , Germany
Patients applied
Trial Officials
Luzia Valentini, Doctor
Principal Investigator
Charite University, Berlin, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials